Editorial: Japan vaccine rollout should prioritize safety, a

Editorial: Japan vaccine rollout should prioritize safety, address fears


news
Editorial: Japan vaccine rollout should prioritize safety, address fears
The Mainichi
© The Mainichi
Screening of new coronavirus vaccines has begun in Japan, with American firm Pfizer Inc. applying to the Ministry of Health, Labor and Welfare for special approval of the vaccine it developed.
A number of countries have already green-lit use of Pfizer's vaccine, and vaccinations have started in the U.S., U.K. and elsewhere. But the normal procedures have been truncated, leaving open the possibility of unexpected side effects. Tests in this country should go ahead with safety as their highest priority.
Vaccinations produce antibodies in inoculated people to fight pathogens and prevent infection or reduce the severity of symptoms.

Related Keywords

Japan , United States , Japanese , American , , Pfizer , Japanese Society For Vaccinology , Pfizer Inc , Ministry Of Health , Immunization Act , Japanese Society , ஜப்பான் , ஒன்றுபட்டது மாநிலங்களில் , ஜப்பானிய , அமெரிக்கன் , ஃபைசர் , ஜப்பானிய சமூகம் க்கு தடுப்பூசி , ஃபைசர் இன்க் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , நோய்த்தடுப்பு நாடகம் , ஜப்பானிய சமூகம் ,

© 2025 Vimarsana